Patient: Time of surgery (min) Gln conc (sample A) Gln conc (sample B) Gln variation Gln variation (%) Creatinine (mg/dL)
1 5 2.3 1.69 reduced 26 0.6
2 8 2.04 1.61 reduced 21 0.54
3 11 2.1 1.65 reduced 21.4 0.45
4 6 1.98 1.53 reduced 22.7 0.78
5 12 2.56 2.01 reduced 21.5 0.69
6 10 1.99 1.24 reduced 37.6 0.64
7 11 2.02 1.53 reduced 23.8 0.74
8 11 2.6 2.01 reduced 22.6 0.82
9 8 2.45 1.33 reduced 45.7 0.72
10 9 2.68 1.08 reduced 59.7 0.7
11 9 2.79 1.74 reduced 43.7 0.7
12 7 2.34 1.57 reduced 32.9 0.64
13 8 2.88 2.07 reduced 28 0.67
14 11 2.53 1.77 reduced 30 0.54
15 13 2.64 2.02 reduced 23.4 0.56
16 14 2.22 1.63 reduced 22.2 0.73
17 15 2.08 1.55 reduced 23.2 0.7
18 9 2.2 1.56 reduced 29 0.6
19 7 2.3 2 reduced 13 0.6
20 9 2.04 1.71 reduced 16 0.6
21 5 2.1 1.8 reduced 14 0.69
22 8 2.31 2.69 increased 16.4 0.5
23 7 2.01 2.4 increased 19.4 0.6
Table 2: Plasmatic levels of glutamine measured in patients belonging to the placebo group.